PRINT THIS PAGE Why biotech VCs are looking North: the Canadian biotech market09/02/2005. Source: Canadian Consulate Trade Office. Arash M. Davallou
The CCTO look at why Canada is the second largest biotech community in the world after the US with 470 public and private companies operating in the sector, focusing on the range of foreign VC investments being made in the country. The organisation also looks at when embryonic stem cell research is eligible for funding, the incentives and commercialisation support private equity firms can apply for, and therapeutic biotech products under development or currently on the Canadian market.
Click here to view full presentation (pdf 710kb) You need Adobe Acrobat to read this document. If you do not have it, you can download it free from www.adobe.com/products/acrobat/readstep.html
Arash M. Davallou works for the Life Sciences Business Development arm of the Canadian Consulate Trade Office in Silicon Valley. They act as business development bridge between Northern California and Canada and operate the Life Sciences Venture Capital Financing Program, a forum through which Canadian companies make
presentations to Bay Area VC firms. For more information visit www.SanFrancisco.gc.ca
|
